Inventor
MACCORMICK SOMHAIRLE
GB18 patents
⚠️ This page may combine multiple inventors who share the name “MACCORMICK SOMHAIRLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KARUS THERAPEUTICS LTD
6 patentsUS10407435B2Sep 10, 2019
Diheteroaryl histone deacetylase inhibitors and their use in therapy
KARUS THERAPEUTICS LTD6 citations69
US9862685B2Jan 9, 2018
Histone deacetylase inhibitors
KARUS THERAPEUTICS LTD4 citations69
US10150763B2Dec 11, 2018
Histone deacetylase inhibitors and their use in therapy
KARUS THERAPEUTICS LTD3 citations68
US9676765B2Jun 13, 2017
Histone deacetylase inhibitors and their use in therapy
KARUS THERAPEUTICS LTD4 citations68
US10533003B2Jan 14, 2020
Polyheteroarl histone deacetylase inhibitors and their use in therapy
KARUS THERAPEUTICS LTD1 citations59
US10870624B2Dec 22, 2020
Histone deacetylase inhibitors
KARUS THERAPEUTICS LTD0 citations48
CHARRIER JEAN-DAMIEN
4 patentsUS8841308B2Sep 23, 2014
Pyrazin-2-amines useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN54 citations98
US8410112B2Apr 2, 2013
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN56 citations93
US8623869B2Jan 7, 2014
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN20 citations84
US8877759B2Nov 4, 2014
Aminopyrazines as ATR kinase inhibitors
CHARRIER JEAN-DAMIEN16 citations83
VERTEX PHARMA
4 patentsUS9701674B2Jul 11, 2017
Substituted pyrazines as ATR kinase inhibitors
VERTEX PHARMA22 citations94
US9365557B2Jun 14, 2016
Substituted pyrazin-2-amines as inhibitors of ATR kinase
VERTEX PHARMA27 citations94
US10961232B2Mar 30, 2021
Substituted pyrazines as ATR kinase inhibitors
VERTEX PHARMA2 citations73
US10479784B2Nov 19, 2019
Substituted pyrazin-2-amines as inhibitors of ATR kinase
VERTEX PHARMA3 citations72